European Journal of Cancer · 2022 · 22 citations · 28 references
MedicineOncologyPharmacologyMetastasisMolecular OncologyNeoplasiaMalignant NeoplasmsMelanocytic TumorsMelanoma PharmacotherapyMetastatic Cancer ManagementMetastatic Disease TreatmentTargeted Cancer TherapyMek InhibitionMek InhibitorsMek SignalingMetastatic Melanoma TreatmentNras MutationRaf-mek-erk SignalingRetrospective Case Study
28
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert, Jacob Schachter, Georgina V. Long et al. · New England Journal of Medicine · 2015 · 5.8K citations · Full text
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
James Larkin, Paolo A. Ascierto, Brigitte Dréno et al. · New England Journal of Medicine · 2014 · 2K citations · Full text
Medicine, Oncology, Pharmacology +16
F. Stephen Hodi, Vanna Chiarion‐Sileni, René González et al. · The Lancet Oncology · 2018 · 1.4K citations
Life Sciences, Immunology, Oncology +16